[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR9906862A - Use of an effective amount of a hormone replacement agent for the treatment of human menopause and endometriosis - Google Patents

Use of an effective amount of a hormone replacement agent for the treatment of human menopause and endometriosis

Info

Publication number
BR9906862A
BR9906862A BR9906862-1A BR9906862A BR9906862A BR 9906862 A BR9906862 A BR 9906862A BR 9906862 A BR9906862 A BR 9906862A BR 9906862 A BR9906862 A BR 9906862A
Authority
BR
Brazil
Prior art keywords
treatment
endometriosis
effective amount
hormone replacement
menopause
Prior art date
Application number
BR9906862-1A
Other languages
Portuguese (pt)
Inventor
Hendrik J De Koning Gans
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BR9906862A publication Critical patent/BR9906862A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"USO DE UMA QUANTIDADE EFICAZ DE UM AGENTE DESUBSTITUIçãO HORMONAL PARA O TRATAMENTO DEMENOPAUSA HUMANA E DE ENDOMETRIOSE". Um aspectoda presente invenção é o uso no tratamento de menopausahumana, de uma quantidade eficaz para fins de menopausa de umagente de substituição hormonal selecionado de um grupocomposto de um progestogênio e de um progestogênio mais umestrogênio. Outro aspecto da presente invenção é o tratamento deendometriose."USE OF AN EFFECTIVE AMOUNT OF A HORMONAL DISUBSTITUTION AGENT FOR THE TREATMENT OF HUMAN DEMENOPAUSE AND ENDOMETRIOSIS". One aspect of the present invention is the use in the treatment of human menopause, an effective amount for menopause purposes of a hormone replacement agent selected from a group consisting of a progestin and a progestin plus an estrogen. Another aspect of the present invention is the treatment of endometriosis.

BR9906862-1A 1998-10-09 1999-10-06 Use of an effective amount of a hormone replacement agent for the treatment of human menopause and endometriosis BR9906862A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10369998P 1998-10-09 1998-10-09
US12682499P 1999-03-30 1999-03-30
PCT/US1999/020904 WO2000021511A2 (en) 1998-10-09 1999-10-06 Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis

Publications (1)

Publication Number Publication Date
BR9906862A true BR9906862A (en) 2001-11-27

Family

ID=26800754

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9906862-1A BR9906862A (en) 1998-10-09 1999-10-06 Use of an effective amount of a hormone replacement agent for the treatment of human menopause and endometriosis

Country Status (6)

Country Link
EP (1) EP1052980A1 (en)
JP (1) JP2002527380A (en)
AU (1) AU1197100A (en)
BR (1) BR9906862A (en)
CA (1) CA2311937A1 (en)
WO (1) WO2000021511A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2521471A1 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
PL1660009T3 (en) * 2003-09-03 2015-08-31 Miscon Trading S A Methods for the treatment of endometriosis
US20080306034A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Method of Administering a Therapeutic
UY33103A (en) * 2009-12-15 2011-07-29 Techsphere S A De C V PARENTERAL PHARMACEUTICAL FORMULATION IN SUSPENSION, SUSTAINED RELEASE, IN LOW AND ULTRA LOW DOSE, IN HORMONAL THERAPY IN THE CLIMATE SYNDROME
WO2014143669A1 (en) 2013-03-15 2014-09-18 AbbVie Inc . Compositions for use in treating heavy menstrual bleeding and uterine fibroids
JP2021531236A (en) * 2018-04-19 2021-11-18 アッヴィ・インコーポレイテッド How to treat severe menstrual bleeding
WO2019220189A1 (en) * 2018-05-18 2019-11-21 Hafeez Kalak Abdul Drug delivery system comprising medroxyprogesterone acetate for use in female contraception

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU724127A1 (en) * 1977-02-10 1980-03-30 Всесоюзный Научно-Исследовательский Институт Акушерства И Гинекологии Ovary function determining method
SU686736A1 (en) * 1977-02-10 1979-09-25 Всесоюзный Научно-Исследовательский Институт Акушерства И Гинекологии Method of treating endocrine gynecologic diseases
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
HU222501B1 (en) * 1991-06-28 2003-07-28 Endorecherche Inc. Controlled release pharmaceutical composition containing mpa or mga and process for its preparation

Also Published As

Publication number Publication date
AU1197100A (en) 2000-05-01
WO2000021511A2 (en) 2000-04-20
WO2000021511A3 (en) 2000-11-30
CA2311937A1 (en) 2000-04-20
JP2002527380A (en) 2002-08-27
EP1052980A1 (en) 2000-11-22

Similar Documents

Publication Publication Date Title
ES2602823T3 (en) Process for the preparation of drospirenone
ATE241361T1 (en) HORMONAL CONTRACEPTION MEANS
DE122007000011I1 (en) Solid dosage forms containing clathrates of the steroidal sex hormone ethinyl estradiol
CY2009015I1 (en) PHARMACEUTICAL COMBINATION OF ETHINYLESTRADIOL AND DROPIRENONE FOR CONTRACEPTIVE USE
AR046671A1 (en) EXTENDED USE OF COMBINATION THAT INCLUDES STROGENS AND PROGESTINES
DK1443966T3 (en) Method of preventing or treating benign gynecological disorders
BR9908094A (en) Combined estrogen and antiestrogen preparation
AU6717298A (en) Agent for hormonal contraception and/or treatment and/or prophylaxis of mammary glands with three hormone components
HK1210708A1 (en) Hormonal composition consisting of an oestrogen compound and of a progestational compound
BR0214716A (en) Contraceptives to prevent pregnancy and decrease premenstrual symptoms
HRP20030387A2 (en) Use of antiprogestins for prophylaxis and treatment of hormone dependent diseases
PT1079790E (en) USE OF MICROBICIDES AND SPERMICIDES FOR INACTIVATION OF VIRUSES WITHOUT ENVELOPE
BR9906862A (en) Use of an effective amount of a hormone replacement agent for the treatment of human menopause and endometriosis
BR0210101A (en) Antineoplastic Combinations
SI1227814T1 (en) Hormonal composition based on nomegestrol acetate and an oestrogen and use thereof
BR0014198A (en) Process for the therapeutic management of extra-uterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
EP1857111A3 (en) Composition comprising a combination of an aromatase inhibitor, a progestin and an estrogen, and its use for the treatment of endometriosis
ATE419855T1 (en) THERAPY FOR HORMONE REPLACEMENT AND DEPRESSION CONTAINING DIENOGEST
BR0213466A (en) Use of (11beta, 17beta) -11- (1,3-benzodioxol-s-yl) -17-hydroxy-17- (1-propynyl) estra-4,9-dien-3-one, pharmaceutical preparation, and, Method for treating a patient suffering from severe depressive disorder
BR9806210A (en) Processes for male contraception and for androgen replacement therapy, male contraceptives, and dosage form for androgen replacement therapy.
BR0112791A (en) 16alpha-substituted steroidal compound, use thereof, treatment methods for selective activation of alpha subtype estrogen receptors, and for hormone replacement therapy or contraception, and, pharmaceutical composition
DE4494826D2 (en) Oral estrogenic esters of 14alpha, 15alpha-methylene-estradiol
EA200300480A1 (en) APPLICATION OF ANTI-PROGESTINES FOR PREVENTION AND TREATMENT OF HORMONIZED DISEASES
IL129900A0 (en) Budenoside for the treatment of cholestatic liver diseases
HUP9801691A2 (en) Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired